Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.
1. A method of stereoselective or regioselective synthesis through ring opening of aziridinium ions, comprising:
converting a substituted β amino alcohol to a substituted alkylating agent;
converting the substituted alkylating agent in the presence of halosequestering agent selected from AgClO 4 , AgOTf, Ag 2 CO 3 , AgOTs, AgNO 3 , AgSbF 6 , or AgBF 4 to a substituted aziridinium ion selected from:
where: Y is a halide or a non-nucleophilic counter anion selected from perchlorate or tetrafluoroborate; each of R 1-4 independently is hydrogen, carboxyalkyl, alkylamido, alkyl, allyl, benzyl, benzyloxyalkyl, cycloalkyl, heterocyclyl, alkoxy, aryl, CH 2 Ar, aryloxy, hydroxyaryl, heteroaryl, phenyl, vinyl, alkynyl, alkenyl, substituted carbonyl, halo, haloalkyl, nitrile, oxo, substituted oxo, substituted silyl, thiol, benzhydryl, silyl, substituted carboxyl, hydroxyalkyl, aminoalkyl, alkoxycarbonyl, alkylamido, furannylalkyl, alkylthioalkyl, arylhydroxyalkyl, indanyl, indolylalkyl, naphthylalkyl, imidazolylalkyl, pyridylalkyl, phthalimidyl, maleimidyl, benzothiophenylalkyl, thiophenylalkyl, thioalkyl, thioaryl, thiobenzyl, hydroxy, tosyl, nosyl, a protected amine, carboxyl, carboxyalkyloxy, amino, carboxylic acid, haloalkylamido, aldehyde, alkylamino, amido, trityl, tert-butyloxycarbonyl, carbobenzyloxy, acetyl dimethoxybenzyl, p-methoxybenzyl, any two vicinal carbons of R 1 and R 2 together form a fused ring, any two geminal carbons, R 1 and R 2 are bonded together and form a spiro ring, any of R 1-4 is attached to chiral carbon, or is one of:
where n=1-10 and X is hydrogen, halo, cyano, alkyl, aryl, hydroxyl, nitro, amino, alkylamino, dialkylamino, substituted amine, substituted carbonyl, isocyanate, cyanate ester, protected amine, protected hydroxyl, protected carboxyl, boronic acid, borinic acid, borinate ester, triflate, silyl, substituted silyl, thiocyano, isothiocyano, alkoxy, aryloxy, carboxyl, carboxylic acid, carboxyalkyl, carboxyalkyloxy, ester, amido, aldehydo, alkylamido, haloalkylamido, and R 3-4 can also be:
where: n=1-3; Ar is an aromatic ring bonded to one of the n carbons; R 5 is as defined for R 1 -R 4 ; and R′ independently is OH, NH 2 , NR″ 2 , or OR″, wherein R″ independently is alkyl, tert-butyl, allyl, benzyl, CH 2 Ar, silyl, trityl, an amine protecting group, a carboxyl protecting group, or a hydroxyl protecting group, and Ar in CH 2 Ar represents an aromatic ring; and
stereoselectively or regioselectively reacting the aziridinium ion in situ with a nucleophile in a nucleophilic ring opening reaction to obtain a compound.
2. The method of claim 1 , wherein the substituted alkylating agent is a substituted β-amino halide comprising:
3. The method of claim 1 , further comprising stereoselectively or regioselectively reacting the aziridinium ion with an aromatic compound including:
where X is defined as above; Y is NH, O, or S.
4. The method of claim 3 , wherein the compound is tryptamine.
5. The method of claim 1 , further comprising stereoselectively or regioselectively reacting the aziridinium ion with an organometallic compound or a reducing agent comprising hydride.
6. The method of claim 5 , wherein the compound comprises a chiral alpha amine.
7. The method of claim 1 , further comprising stereoselectively or regioselectively reacting the aziridinium ion with a dialkyl malonic ester.
8. The method of claim 1 , wherein the stereoselective or regioselective reaction of the aziridinium ion is an intramolecular nucleophilic reaction in the presence of a catalyst.
9. The method of claim 1 , wherein the synthesis occurs without isolation of any intermediate compound.
10. A method of stereoselective or regioselective synthesis through ring opening of aziridinium ions, comprising:
converting a substituted β amino alcohol to a substituted aziridinium ion selected from:
where: Y is a halide or a non-nucleophilic counter anion selected from perchlorate or tetrafluoroborate; each of R 1-4 independently is hydrogen, carboxyalkyl, alkylamido, alkyl, allyl, benzyl, benzyloxyalkyl, cycloalkyl, heterocyclyl, alkoxy, aryl, CH 2 Ar, aryloxy, hydroxyaryl, heteroaryl, phenyl, vinyl, alkynyl, alkenyl, substituted carbonyl, halo, haloalkyl, nitrile, oxo, substituted oxo, substituted silyl, thiol, benzhydryl, silyl, substituted carboxyl, hydroxyalkyl, aminoalkyl, alkoxycarbonyl, alkylamido, furannylalkyl, alkylthioalkyl, arylhydroxyalkyl, indanyl, indolylalkyl, naphthylalkyl, imidazolylalkyl pyridylalkyl, phthalimidyl, maleimidyl, benzothiophenylalkyl, thiophenylalkyl, thioalkyl, thioaryl, thiobenzyl, hydroxy, tosyl, nosyl, a protected amine, carboxyl, carboxyalkyloxy, amino, carboxylic acid, haloalkylamido, aldehyde, alkylamino, amido, trityl, tert-butyloxycarbonyl, carbobenzyloxy, acetyl, dimethoxybenzyl, p-methoxybenzyl, any two vicinal carbons of R 1 and R 2 together form a fused ring, any two geminal carbons, R 1 and R 2 are bonded together and form a spiro ring, any of R 1-4 is attached to chiral carbon, or is one of:
where n=1-10 and X is hydrogen, halo, cyano, alkyl, aryl, hydroxyl, nitro, amino, alkylamino, dialkylamino, substituted amine, substituted carbonyl, isocyanate, cyanate ester, protected amine, protected hydroxyl, protected carboxyl, boronic acid, borinic acid, borinate ester, triflate, silyl, substituted silyl, thiocyano, isothiocyano, alkoxy, aryloxy, carboxyl, carboxylic acid, carboxyalkyl, carboxyalkyloxy, ester, amido, aldehydo, alkylamido, haloalkylamido, and R 3-4 can also be:
where: n=1-3; Ar is an aromatic ring bonded to one of the n carbons; R 5 is as defined for R 1 -R 4 ; and R′ independently is OH, NH 2 , NR″ 2 , or OR″, wherein R″ independently is alkyl, tert-butyl, allyl, benzyl, CH 2 Ar, silyl, trityl, an amine protecting group, a carboxyl protecting group, or a hydroxyl protecting group, and Ar in CH 2 Ar represents an aromatic ring; and
stereoselectively or regioselectively reacting the aziridinium ion in a nucleophilic ring opening reaction with a nucleophile selected from:
where m is 0 or 1 and R′ independently is OH, NH 2 , NR 2 ″, or OR″, wherein R″ independently is alkyl, tert-butyl, allyl, benzyl, CH 2 Ar, silyl, trityl, an amine protecting group, a carboxyl protecting group, or a hydroxyl protecting group, and each of R 7-9 are as defined above for R 1-5 ; any two vicinal carbons of R 7-9 together form a fused ring; any of R 7-9 is or is attached to chiral carbon; or one of:
where X is as defined above, to obtain a compound.
11. The method of claim 10 , further comprising:
converting a substituted β amino alcohol to a substituted alkylating agent;
converting the substituted alkylating agent to the substituted aziridinium ion; and
stereoselectively or regioselectively reacting the aziridinium ion with a nucleophile to obtain the compound.
12. The method of claim 11 , further comprising:
converting the substituted alkylating agent to the aziridinium ion in the presence of halosequestering agent selected from AgClO 4 , AgOTf, Ag 2 CO 3 , AgOTs, AgNO 3 , AgSbF 6 , or AgBF 4 ; and
stereoselectively or regioselectively reacting the aziridinium ion in situ with a nucleophile to obtain the compound.
13. The method of claim 10 , wherein the compound is one of:
14. The method of claim 13 , further comprising removing a protecting group selected from an amino, a carboxyl, or a hydroxyl protecting group from the compound using a deprotection reaction.
15. The method of claim 14 , further comprising converting a nitro group in the compound to an amino group.
16. The method of claim 15 , further comprising converting an amino group to an isothiocyanate group.
17. The method of claim 10 , further comprising:
converting the substituted alkylating agent to the aziridinium ion in the presence of halosequestering agent selected from AgClO 4 , AgOTf, Ag 2 CO 3 , AgOTs, AgNO 3 , AgSbF 6 , or AgBF 4 ; and
stereoselectively or regioselectively reacting the aziridinium ion in situ with the nucleophile in the presence of a base to obtain the compound.
18. The method of claim 10 , further comprising:
converting a substituted β amino alcohol to a substituted alkylating agent;
converting the substituted alkylating agent to the substituted aziridinium ion; and
stereoselectively or regioselectively reacting the aziridinium ion with a nucleophile to obtain the compound, wherein the reaction occurs without isolation of any intermediate compound.
19. A method of stereoselective or regioselective synthesis through ring opening of aziridinium ions, comprising:
converting a substituted β amino alcohol to a substituted alkylating agent;
converting the substituted alkylating agent to a substituted aziridinium ion in the presence of halosequestering agent selected from AgClO 4 , AgOTf, Ag 2 CO 3 , AgOTs, AgNO 3 , AgSbF 6 , or AgBF 4 ; and
stereoselectively or regioselectively reacting the aziridinium ion in situ with a nucleophile in a nucleophilic ring opening reaction to obtain a compound, wherein the synthesis occurs without isolation of any intermediate compound.
20. The method of claim 19 , wherein the aziridinium ion is:
where: Y is a halide, a perchlorate, or tetrafluoroborate, each of R 1-2 , independently is hydrogen, carboxyalkyl, alkylamido, alkyl, allyl, benzyl, benzyloxyalkyl, cycloalkyl, alkoxy, hydroxyalkyl, aryl, aryloxy, hydroxyaryl, heteroaryl, phenyl, vinyl, alkynyl, alkenyl, furannylalkyl, alkylthioalkyl, arylhydroxyalkyl, indanyl, indolylalkyl, naphthylalkyl , imidazolylalkyl, pyridylalkyl, benzothiophenylalkyl, thiophenylalkyl , thioalkyl, thioaryl, thiobenzyl, carboxyl, carboxyalkyloxy, aldehyde, ester, amido, or a protecting group, and each of R 3-4 independently comprises a tert-butyl group or a benzyl group.